eli lilly empower pharmacy

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss drugs tirzepatide and semaglutide.

Houston Public Media · 1d

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

Health News Florida · 1d

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.

Fierce Pharma1d

Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

1don MSN

Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...

Pharmaceutical Technology on MSN1d

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Trending now